Search Login Register

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Summary

Description: Group of systemic vasculitis with a strong association with ANCA. The disorders are characterized by necrotizing inflammation of small and medium size vessels, with little or no immune-complex deposits in vessel walls.

Also Known As: ANCA Associated Vasculitides; ANCA Associated Vasculitis; ANCA-Associated Vasculitide; Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis; Pauci Immune Vasculitis Show All >>

Networked: 890 relevant articles (81 outcomes, 113 trials/studies) for this Disease

Key Drugs and Agents for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Antineutrophil Cytoplasmic Antibodies (ANCA) : 33 outcomes 50 studies in 528 results : IBA
  2. rituximab (Mabthera) : 32 outcomes 27 studies in 108 results : FDA 3
  3. Cyclophosphamide (Cytoxan) : 26 outcomes 18 studies in 75 results : FDA 10 Generic
  4. Azathioprine (Imuran) : 11 outcomes 8 studies in 28 results : FDA 7 Generic
  5. Peroxidase (Myeloperoxidase) : 7 outcomes 16 studies in 95 results : IBA
  6. Prednisolone (Predate) : 5 outcomes 1 study in 9 results : FDA 55 Generic
  7. Immunosuppressive Agents (Immunosuppressants) : 4 outcomes in 8 results : IBA
  8. Glucocorticoids : 3 outcomes in 13 results : IBA
  9. Myeloblastin (Proteinase 3) : 2 outcomes 4 studies in 38 results : IBA
  10. Autoantibodies : 2 outcomes 2 studies in 34 results : IBA
Show All >>

Diseases Related to Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

  1. Vasculitis (Vasculitides)
  2. Systemic Lupus Erythematosus (Libman-Sacks Disease)
  3. Inflammation
  4. Infection
  5. Microscopic Polyangiitis
Show All >>

Key Therapies for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Efficacy Chart >>
  1. Remission Induction : 8 outcomes 8 studies in 29 results
  2. Plasmapheresis : 3 outcomes 1 study in 7 results
  3. Kidney Transplantation : 2 outcomes 1 study in 17 results
  4. Plasma Exchange : 1 outcome 2 studies in 11 results
  5. Aftercare (After-Treatment) : 1 outcome 1 study in 2 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.